Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics
Abstract To investigate the role of quantitative ultrasound (QUS) radiomics to predict treatment response in patients with head and neck squamous cell carcinoma (HNSCC) treated with radical radiotherapy (RT). Five spectral parameters, 20 texture, and 80 texture-derivative features were extracted fro...
Guardado en:
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71fe57975a2c4ff8af62d83d2064dff7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:71fe57975a2c4ff8af62d83d2064dff7 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:71fe57975a2c4ff8af62d83d2064dff72021-12-02T17:05:11ZAssessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics10.1038/s41598-021-85221-62045-2322https://doaj.org/article/71fe57975a2c4ff8af62d83d2064dff72021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-85221-6https://doaj.org/toc/2045-2322Abstract To investigate the role of quantitative ultrasound (QUS) radiomics to predict treatment response in patients with head and neck squamous cell carcinoma (HNSCC) treated with radical radiotherapy (RT). Five spectral parameters, 20 texture, and 80 texture-derivative features were extracted from the index lymph node before treatment. Response was assessed initially at 3 months with complete responders labelled as early responders (ER). Patients with residual disease were followed to classify them as either late responders (LR) or patients with persistent/progressive disease (PD). Machine learning classifiers with leave-one-out cross-validation was used for the development of a binary response-prediction radiomics model. A total of 59 patients were included in the study (22 ER, 29 LR, and 8 PD). A support vector machine (SVM) classifier led to the best performance with accuracy and area under curve (AUC) of 92% and 0.91, responsively to define the response at 3 months (ER vs. LR/PD). The 2-year recurrence-free survival for predicted-ER, LR, PD using an SVM-model was 91%, 78%, and 27%, respectively (p < 0.01). Pretreatment QUS-radiomics using texture derivatives in HNSCC can predict the response to RT with an accuracy of more than 90% with a strong influence on the survival. Clinical trial registration: clinicaltrials.gov.in identifier NCT03908684.Laurentius Oscar OsapoetraArchya DasguptaDaniel DiCenzoKashuf FatimaKarina QuiaoitMurtuza SaifuddinIrene KaramIan PoonZain HusainWilliam T. TranLakshmanan SannachiGregory J. CzarnotaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-13 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Laurentius Oscar Osapoetra Archya Dasgupta Daniel DiCenzo Kashuf Fatima Karina Quiaoit Murtuza Saifuddin Irene Karam Ian Poon Zain Husain William T. Tran Lakshmanan Sannachi Gregory J. Czarnota Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics |
description |
Abstract To investigate the role of quantitative ultrasound (QUS) radiomics to predict treatment response in patients with head and neck squamous cell carcinoma (HNSCC) treated with radical radiotherapy (RT). Five spectral parameters, 20 texture, and 80 texture-derivative features were extracted from the index lymph node before treatment. Response was assessed initially at 3 months with complete responders labelled as early responders (ER). Patients with residual disease were followed to classify them as either late responders (LR) or patients with persistent/progressive disease (PD). Machine learning classifiers with leave-one-out cross-validation was used for the development of a binary response-prediction radiomics model. A total of 59 patients were included in the study (22 ER, 29 LR, and 8 PD). A support vector machine (SVM) classifier led to the best performance with accuracy and area under curve (AUC) of 92% and 0.91, responsively to define the response at 3 months (ER vs. LR/PD). The 2-year recurrence-free survival for predicted-ER, LR, PD using an SVM-model was 91%, 78%, and 27%, respectively (p < 0.01). Pretreatment QUS-radiomics using texture derivatives in HNSCC can predict the response to RT with an accuracy of more than 90% with a strong influence on the survival. Clinical trial registration: clinicaltrials.gov.in identifier NCT03908684. |
format |
article |
author |
Laurentius Oscar Osapoetra Archya Dasgupta Daniel DiCenzo Kashuf Fatima Karina Quiaoit Murtuza Saifuddin Irene Karam Ian Poon Zain Husain William T. Tran Lakshmanan Sannachi Gregory J. Czarnota |
author_facet |
Laurentius Oscar Osapoetra Archya Dasgupta Daniel DiCenzo Kashuf Fatima Karina Quiaoit Murtuza Saifuddin Irene Karam Ian Poon Zain Husain William T. Tran Lakshmanan Sannachi Gregory J. Czarnota |
author_sort |
Laurentius Oscar Osapoetra |
title |
Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics |
title_short |
Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics |
title_full |
Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics |
title_fullStr |
Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics |
title_full_unstemmed |
Assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics |
title_sort |
assessment of clinical radiosensitivity in patients with head-neck squamous cell carcinoma from pre-treatment quantitative ultrasound radiomics |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/71fe57975a2c4ff8af62d83d2064dff7 |
work_keys_str_mv |
AT laurentiusoscarosapoetra assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT archyadasgupta assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT danieldicenzo assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT kashuffatima assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT karinaquiaoit assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT murtuzasaifuddin assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT irenekaram assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT ianpoon assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT zainhusain assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT williamttran assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT lakshmanansannachi assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics AT gregoryjczarnota assessmentofclinicalradiosensitivityinpatientswithheadnecksquamouscellcarcinomafrompretreatmentquantitativeultrasoundradiomics |
_version_ |
1718381796216799232 |